TAMs guide tumor cells to blood vessels, disrupting the endothelial barriers for intravasation. TAMs and microglia promote tumor invasiveness through non-phagocytic interactions. NETs capture CTCs and promote adhesion, immune evasion, and extravasation. CAFs enhance CTC survival via RANTES and ICAM1. This evidence concerns the gene CCL5 and neoplasm.